IGLC2 and diabetes mellitus: The overlap in plasma concentrations of both REG1A and IGLC2 in patients affected by diabetes with (DC) and without CHD (DN) (box plot of Figure 1; close vector angle in PCA plot of Figure 2) supports a role of these plasma proteins throughout the time course evolution of diabetic cardiorenal disease.